CLOROTEKAL

Reason for request

Clinical Benefit

Substantial

The actual benefit of CLOROTEKAL in the Marketing Authorisation indication is substantial.

Clinical Added Value

no clinical added value

CLOROTEKAL does not provide an improvement in actual benefit (non existent IAB) compared with other intrathecal local anaesthetics.